Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients
Crossref DOI link: https://doi.org/10.1007/s40268-015-0087-7
Published Online: 2015-03-06
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boffito, Marta
Jackson, Akil
Pozniak, Anton
Giraudon, Mylene
Kulkarni, Rohit
Abelardo, Maria Connie
Patel, Indravadan H.
Morcos, Peter N.
License valid from 2015-03-01